Spain to Produce Janssen's COVID-19 Vaccine

REIG JOFRE, a pharmaceutical company based in Spain, announced it has reached an agreement with the Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen), to execute the technology transfer to manufacture its investigational COVID-19 vaccine candidate, Ad26.COV2-S.

Ignasi Biosca, CEO of REIG JOFRE, stated in a press release issued on December 15, 2020: “Having been chosen by Janssen as one of its partners for the manufacturing of its Ad26.COV2-S vaccine candidate will give REIG JOFRE the opportunity to prove the strategic value that strong, competitive, and technologically advanced industries can play in overcoming such difficult situations as the one we are facing at present.”